Product
Carboplatin + Paclitaxel + Durvalumab
1 clinical trial
1 indication
Indication
Extensive-Stage Small Cell Lung CancerClinical trial
A Phase II Study Assessing the Efficacy of Etoposide Free Chemotherapy Plus Durvalumab (MEDI4736) in First Line Extensive Disease Small Cell Lung Cancer (SCLC)Status: Recruiting, Estimated PCD: 2026-02-01